Breast Cancer Diagnosis and Prognosis through Quantitative Measurements of Serum Glycan Profiles | Zendy

Zuzana Kyseľová | Zendy; Yehia Mechref | Zendy; Pilsoo Kang | Zendy; John A. Goetz | Zendy; Lacey E. Dobrolecki | Zendy; George W. Sledge | Zendy; Lauren A. Schnaper | Zendy; Robert J. Hickey | Zendy; Linda H. Malkas | Zendy; Miloš V. Novotný | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Breast Cancer Diagnosis and Prognosis through Quantitative Measurements of Serum Glycan Profiles

Author(s) -

Zuzana Kyseľová,

Yehia Mechref,

Pilsoo Kang,

John A. Goetz,

Lacey E. Dobrolecki,

George W. Sledge,

Lauren A. Schnaper,

Robert J. Hickey,

Linda H. Malkas,

Miloš V. Novotný

Publication year - 2008

Publication title -

clinical chemistry

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.705

H-Index - 218

eISSN - 1530-8561

pISSN - 0009-9147

DOI - 10.1373/clinchem.2007.087148

Subject(s) - glycan , fucosylation , glycosylation , glycomics , breast cancer , glycoprotein , cancer , chemistry , glycome , computational biology , biochemistry , biology , genetics

Glycosylated proteins play important roles in cell-to-cell interactions, immunosurveillance, and a variety of receptor-mediated and specific protein functions through a highly complex repertoire of glycan structures. Aberrant glycosylation has been implicated in cancer for many years.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research